Peter A. Lando
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Toxin Mechanisms and Immunotoxins
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Immunology 28
- Immunotherapy and Immune Responses 14
- Immune Cell Function and Interaction 12
- T-cell and B-cell Immunology 11
- Immune Response and Inflammation 8
- Toxin Mechanisms and Immunotoxins 2
- Oncology 11
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Mikael Dohlsten (26 shared papers)Terje Kalland (24 shared papers)Gunnar Hedlund (10 shared papers)Lennart Ohlsson (8 shared papers)Thomas Brodin (4 shared papers)Eva Åkerblom (3 shared papers)Peter Lind (5 shared papers)Lars Abrahmsén (2 shared papers)
- Journals
- Cancer Immunology Immunotherapy (5 papers)The Journal of Immunology (4 papers)European Journal of Immunology (3 papers)Proceedings of the National Academy of Sciences (2 papers)Immunotechnology (1 paper)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Peter A. Lando
30 papers receiving 911 citations
Peers
Comparison fields: 5 of 65
- Immunology 666
- Radiology, Nuclear Medicine and Imaging 260
- Biotechnology 76
- Oncology 198
- Immunology and Allergy 35
Countries citing papers authored by Peter A. Lando
This map shows the geographic impact of Peter A. Lando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Lando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Lando more than expected).
Fields of papers citing papers by Peter A. Lando
This network shows the impact of papers produced by Peter A. Lando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Lando. The network helps show where Peter A. Lando may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter A. Lando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 107 | |
| 2 | 1991 | 89 | |
| 3 | 1996 | 60 | |
| 4 | Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins. | 1990 | 58 |
| 5 | 1995 | 55 | |
| 6 | 2001 | 54 | |
| 7 | 1990 | 51 | |
| 8 | 1991 | 48 | |
| 9 | 1991 | 47 | |
| 10 | 2000 | 45 | |
| 11 | 1996 | 42 | |
| 12 | 1991 | 36 | |
| 13 | 1991 | 32 | |
| 14 | 1991 | 30 | |
| 15 | 1996 | 23 | |
| 16 | 1997 | 20 | |
| 17 | 1995 | 19 | |
| 18 | 1985 | 17 | |
| 19 | 1993 | 16 | |
| 20 | Co-stimulation with B7 and targeted superantigen is required for MHC class II-independent T-cell proliferation but not cytotoxicity. | 1993 | 16 |
About Peter A. Lando
Peter A. Lando is a scholar working on Immunology, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 30 papers that have together received 940 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (14 papers), Immune Cell Function and Interaction (12 papers), T-cell and B-cell Immunology (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Immune Response and Inflammation (8 papers), CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Toxin Mechanisms and Immunotoxins (2 papers). The work is most often cited by research in Immunology (666 citations), Radiology, Nuclear Medicine and Imaging (260 citations), Biotechnology (76 citations), Oncology (198 citations) and Immunology and Allergy (35 citations). Peter A. Lando has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Mikael Dohlsten, Terje Kalland, Gunnar Hedlund, Lennart Ohlsson, Thomas Brodin, Eva Åkerblom, Peter Lind, Lars Abrahmsén, G. Forsberg and P. Björk. Their work appears in journals such as Cancer Immunology Immunotherapy, The Journal of Immunology, European Journal of Immunology, Proceedings of the National Academy of Sciences and Immunotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.